Parsaclisib is a medication being studied for its ability to help treat certain types of cancer. It works by blocking specific proteins in the body that help cancer cells grow. In this trial, participants who were already taking Parsaclisib in previous studies can continue their treatment to see if it remains safe and effective over a longer period.

Itacitinib is another medication involved in this trial. It is used to help manage conditions related to the immune system. Itacitinib works by interfering with certain signals in the body that can cause inflammation and other immune responses. In this study, it is being used in combination with Parsaclisib to see if the two medications together can provide better results for patients.

Ruxolitinib is a medication that helps reduce inflammation and is often used to treat certain blood disorders. It works by blocking specific enzymes in the body that contribute to inflammation and abnormal blood cell production. In this trial, Ruxolitinib is being combined with Parsaclisib to evaluate if this combination can improve treatment outcomes for patients.

Ibrutinib is a medication that targets certain proteins in cancer cells, helping to slow down or stop their growth. It is commonly used to treat various types of blood cancers. In this study, Ibrutinib is being used alongside Parsaclisib to determine if the combination is more effective than using either medication alone.

Tafasitamab is a medication that helps the immune system recognize and attack cancer cells. It is often used in the treatment of certain types of lymphoma. In this trial, Tafasitamab is being used both in combination with Parsaclisib and on its own to see how well it works in treating patients who have been part of previous studies.

Advanced Malignancies – Advanced malignancies refer to cancers that have progressed to a late stage, often spreading beyond their original site to other parts of the body. These malignancies can affect various organs and tissues, leading to a range of symptoms depending on the location and extent of the spread. As the disease progresses, it may cause significant changes in bodily functions and overall health. The progression can vary greatly depending on the type of cancer and individual patient factors. Advanced malignancies often require complex management due to their widespread impact on the body. The disease can lead to a decline in physical abilities and quality of life as it advances.

Idiopathic Autoimmune Diseases – Idiopathic autoimmune diseases are conditions where the immune system mistakenly attacks the body’s own tissues, and the exact cause of this immune response is unknown. These diseases can affect various parts of the body, leading to inflammation and damage to healthy tissues. The progression of idiopathic autoimmune diseases can vary widely, with some individuals experiencing mild symptoms and others facing severe complications. Over time, these diseases can lead to chronic pain, fatigue, and organ dysfunction. The course of the disease is often unpredictable, with periods of remission and flare-ups. As the disease progresses, it can significantly impact daily life and overall well-being.